SEC Form 4 · accession 0001209191-15-048896
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark S Shearman
Officer — Chief Scientific Officer
Period of report
Jun 1, 2015
Accepted (ET)
Jun 2, 2015 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $19.50 | Jun 1, 2015 | A | 110,000 | A | — | Jun 1, 2025 | Common Stock | 110,000 | 110,000 | D |
Explanation of responses
- F1Option becomes exercisable for 25% of the underlying shares on the first anniversary of the hire date, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares on the fourth anniversary of the hire date.